Tirzepatide: The Next Diabetes Treatment?

Tirzepatide: The Next Diabetes Treatment?

Tirzepatide is a novel drug that works as an agonist of both GLP-1 and GIP. How does this compare to semaglutide, a GLP-1 agonist? Join us as we discuss the SURPASS-2 trial, and compare the drugs’ mechanisms of action, effect on hemoglobin A1c, impact on weight, and overall clinical outcomes.

This journal club dissects an article from The New England Journal of Medicine – Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. 

Upon successful completion of this application-based course, pharmacists and pharmacy students should be able to:
1. Describe the mechanism of action of tirzepatide
2. Compare and contrast tirzepatide with semaglutide
3. Discuss clinical trial data on tirzepatide’s effect on hemoglobin A1c at various doses as compared to semaglutide
4. Discuss the impact of tirzepatide on patient weight
5. Develop a conclusion for tirzepatide’s role in patient-centered diabetes care based on a clinical trial

Ellen Jones, PharmD
Assistant Professor
Harding University College of Pharmacy

Ellen Jones has no relevant financial relationships to disclose. 

To obtain 1 contact hour of continuing pharmacy education credit (0.1 CEU), participants must read:

Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021 Aug 5;385(6):503-515. doi: 10.1056/NEJMoa2107519. Epub 2021 Jun 25. PMID: 34170647.

*CEimpact provides you with two (2) opportunities to complete the exam. If there are two failed attempts, the participant will not receive CPE credit.

Fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: April 13, 2022
Planned Expiration Date: April 13, 2025  


Universal Activity Number (UAN): 0107-0000-22-113-H01-P
Application-based CPE Activity

CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.

¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.

Additional information


1h 0m

Topic Designator

Disease State/Drug Therapy



ACPE Topic

01 Drug Therapy





Release Date






ACPE Number


This course is in our subscription.